Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Roowin Transfers its Operations to Riom

Published: Wednesday, December 26, 2012
Last Updated: Wednesday, December 26, 2012
Bookmark and Share
CRO moves into immediately operational premises to handle increase in demand for fine chemistry services, and to bring clients the benefit of facilities.

Roowin SA has announced that it has moved into new premises in Riom, near Clermont-Ferrand, in the Auvergne region.

The move will strengthen Roowin’s position as one of the few companies in France that offers a comprehensive range of services, from early-stage research to the production of GMP batches for phase I and II clinical trials. This relocation also represents a new milestone in the company’s development.

The company is moving into 1,500 square metres of premises at Riom-La Varenne that are currently owned by Schering-Plough. They include laboratories complying with regulatory GLP (good laboratory practice) and GMP (good manufacturing practice) standards, as well as offices and warehousing.

These facilities have 50 per cent more space than Roowin’s old premises and incorporate cutting-edge equipment that will enable the company to increase the quantities that can be produced and offer an even higher quality of the services it provides to its clients.

The new equipment from which its clients will benefit includes an LC/NMR 500 MHz machine combining liquid chromatography with nuclear magnetic resonance for more rapid and accurate screening.

Only a few laboratories in France have access to this technology. In addition, Roowin is now equipped with ultra-performance liquid chromatography/mass spectrometry (UPLC/MS) instruments, infrared equipment, and gas chromatography-mass spectrometry (GC-MS) technology.

In the area of synthesis, Roowin can now undertake low-temperature work as the result of acquiring a liquid nitrogen unit operating at minus 80C.

The move is being welcomed by local authorities. “Keeping industrial activities going at the Schering-Plough site in La Varenne is a priority for Riom town council, the regional development office of the department of Puy de Dome, the Clermont-Ferrand Community, and the Community of District Councils of Limagne-D’Ennezat, one of the founder members of the future joint Biopole Clermont Limagne association,” explained Herve Prevoteau, director of the Clermont Limagne biocluster.

“Roowin is a large independent firm in the fine chemistry sector, and we are going to help it grow still further to our mutual benefit in terms of job and wealth creation. It will find its full place in the pharmaceutical industry of the Auvergne region.”

“It was hard to find a place that corresponded to all our technical needs,” said Patrice Rool, the chairman of Roowin. “That is why we are delighted to be moving to Riom, which offers all the advantages we were looking for. We are planning to develop our activities further and in particular to invest in additional clean rooms.”

Roowin began the move into its new premises on May 1. The operation is being spread over two months to ensure continuity of service to the company’s clientele.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Genome of 6000-Year-Old Barley Sequenced
Researchers have successfully sequenced the genome of Chalcolithic barley grains for the first time.
3D Models May Yield Ovarian Cancer Insights
Researchers are developing new tools to decipher ovarian cancer developments through a 3D printing technology.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!